Global Enteral Nutrition Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product Type;
General and Disease Specific,By Application;
Gastrointestinal Disorders, Metabolic/Inborn Errors of Metabolism, Food Allergy, Renal Disease, Liver Disease, Oncology, Neurology, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Enteral Nutrition Market (USD Million), 2021 - 2031
In the year 2023, the Global Enteral Nutrition Market was valued at USD 6,258.53 million. The size of this market is expected to increase to USD 9,706.51 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.5%.
The global enteral nutrition market is witnessing substantial growth driven by a confluence of factors such as increasing prevalence of chronic diseases, rising geriatric population, advancements in medical technology, and growing awareness about the benefits of enteral nutrition in patient care. Enteral nutrition, which involves the administration of nutrients directly into the gastrointestinal tract through a feeding tube, plays a critical role in providing essential nutrients to patients who are unable to consume food orally due to medical conditions or surgeries.
This includes individuals suffering from conditions such as cancer, gastrointestinal disorders, neurological disorders, and those undergoing surgical procedures or intensive care treatment. The enteral nutrition market encompasses a wide range of products including enteral feeding pumps, feeding tubes, formulae, and accessories, catering to diverse patient needs and clinical settings. With the increasing focus on improving patient outcomes, reducing hospital stays, and enhancing the quality of life, the demand for enteral nutrition products and services is expected to continue its upward trajectory. Ongoing research and development efforts aimed at enhancing the efficacy, safety, and convenience of enteral nutrition products are likely to further fuel market growth, making it a promising sector within the global healthcare industry.
Global Enteral Nutrition Market Recent Developments
-
In September 2023, Abbott announced the plan to boost manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.
-
In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste
Segment Analysis
Product Type segmentation delves into categorizing enteral nutrition products based on their characteristics and formulations. This includes enteral nutrition formulas, enteral nutrition tubes, administration reservoirs, and pump sets. Each of these product types serves distinct purposes within the enteral nutrition system, catering to various patient needs and medical requirements.
Application segmentation focuses on identifying the diverse medical conditions and patient populations that utilize enteral nutrition solutions. These applications encompass a wide range of healthcare settings, including hospitals, ambulatory surgical centers, home care settings, and long-term care facilities. Understanding the specific applications helps in tailoring enteral nutrition products and services to meet the unique needs of different patient groups and clinical scenarios.
Global Enteral Nutrition Segment Analysis
In this report, the Global Enteral Nutrition Market has been segmented by Product Type, Application and Geography.
Global Enteral Nutrition Market, Segmentation by Product Type;
The Global Enteral Nutrition Market has been segmented by Product Type into General and Disease Specific,
The General category encompasses a wide range of enteral nutrition products designed to meet the nutritional needs of individuals who are unable to consume food orally or are at risk of malnutrition. These products typically include standard formulations such as polymeric feeds, which consist of a balanced combination of macronutrients (proteins, carbohydrates, and fats), as well as vitamins, minerals, and trace elements essential for maintaining health. General enteral nutrition products are commonly used in various clinical settings, including hospitals, nursing homes, and home healthcare settings, to support patients recovering from surgery, trauma, or critical illness, as well as those with chronic conditions such as cancer or gastrointestinal disorders.
The Disease Specific category caters to individuals with specific medical conditions or nutritional requirements that necessitate specialized enteral nutrition formulations. These products are tailored to address the unique nutritional needs and therapeutic goals of patients with conditions such as diabetes, renal failure, liver disease, or metabolic disorders. Disease-specific enteral nutrition formulations may contain modified nutrient compositions, such as reduced carbohydrate content for diabetic patients or restricted protein and electrolyte levels for individuals with renal impairment.
The segmentation of the enteral nutrition market into General and Disease Specific categories reflects the diverse and evolving needs of patients requiring specialized nutritional support. Healthcare providers and nutritionists can select from a wide array of enteral nutrition products tailored to meet the specific dietary requirements and clinical conditions of individual patients, thereby optimizing patient outcomes and quality of life. Furthermore, ongoing research and innovation in the field of enteral nutrition are expected to drive the development of advanced formulations and delivery systems, further expanding the range of options available to healthcare professionals and patients alike. As the prevalence of chronic diseases and the aging population continue to rise globally, the demand for enteral nutrition products is projected to increase, thereby fueling market growth in both the General and Disease Specific segments.
Global Enteral Nutrition Market, Segmentation by Application
The Global Enteral Nutrition Market has been segmented by Application into Gastrointestinal Disorders, Metabolic/Inborn Errors of Metabolism, Food Allergy, Renal Disease, Liver Disease, Oncology, Neurology, and Others.
One key application segment is Gastrointestinal Disorders, which encompasses a range of conditions affecting the digestive tract, such as Crohn's disease, ulcerative colitis, and irritable bowel syndrome. Metabolic/Inborn Errors of Metabolism represent another crucial category, addressing genetic disorders like phenylketonuria (PKU) or maple syrup urine disease (MSUD), where specific nutrient management is essential. Food Allergy, another segment, focuses on providing specialized nutrition to individuals with allergies or intolerances to certain foods.
Renal Disease constitutes another vital segment, targeting patients with kidney-related conditions like chronic kidney disease (CKD) or end-stage renal disease (ESRD), who require controlled intake of nutrients to manage their condition. Liver Disease represents a significant application area as well, addressing liver conditions such as cirrhosis, hepatitis, or fatty liver disease, where nutritional support plays a critical role in management.
Oncology, a segment of paramount importance, caters to cancer patients undergoing treatments like chemotherapy or radiation therapy, who often experience nutritional deficiencies due to treatment side effects. Neurology encompasses conditions such as stroke, traumatic brain injury, or neurodegenerative diseases like Alzheimer's or Parkinson's, where enteral nutrition may be necessary for patients with swallowing difficulties or impaired nutrient absorption.
Global Enteral Nutrition Market, Segmentation by Geography
In this report, the Global Enteral Nutrition Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Enteral Nutrition Market Share (%), by Geographical Region, 2024
North America stands out as a prominent market for enteral nutrition products, primarily due to the well-established healthcare infrastructure, high prevalence of chronic diseases, and increasing elderly population. The region also benefits from a robust regulatory framework and high healthcare expenditure, driving the demand for enteral nutrition solutions.
In Europe, factors such as the aging population, rising incidence of malnutrition-related diseases, and growing awareness about the importance of nutritional support contribute to the expansion of the enteral nutrition market. Additionally, advancements in medical technology and increasing adoption of home healthcare services further propel market growth across European countries.
The Asia Pacific region represents a rapidly growing market for enteral nutrition, fueled by factors such as improving healthcare infrastructure, rising healthcare expenditure, and growing awareness about the benefits of enteral feeding among healthcare professionals and patients. Moreover, the region's large population base and increasing incidence of chronic diseases contribute to market expansion.
In the Middle East and Africa, the enteral nutrition market is witnessing steady growth, driven by increasing healthcare investments, rising prevalence of chronic diseases, and growing adoption of enteral feeding techniques. Government initiatives aimed at improving healthcare access and infrastructure also play a significant role in driving market growth in this region.
Latin America presents opportunities for market expansion owing to factors such as improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness about enteral nutrition solutions. The region's large population base and high prevalence of malnutrition-related diseases further contribute to market growth prospects.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Enteral Nutrition Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers, Restraints and Opportunitiy Analysis
Drivers:
- Increasing Prevalence of Chronic Diseases
- Aging Population
-
Increasing Awareness about Clinical Nutrition - One of the key drivers behind the increasing awareness about clinical nutrition is the rising prevalence of chronic diseases worldwide. Chronic conditions such as cancer, diabetes, and gastrointestinal disorders often necessitate specialized nutritional support to manage symptoms, promote healing, and improve overall health outcomes. As healthcare professionals and patients alike recognize the importance of tailored nutrition interventions in managing these conditions, the demand for enteral nutrition products has witnessed a significant upswing.
An aging population demographic, particularly in developed regions, has contributed to the growing emphasis on clinical nutrition. Elderly individuals often face unique nutritional challenges due to age-related changes in metabolism, appetite, and gastrointestinal function. Enteral nutrition formulations tailored to meet the specific needs of geriatric patients have thus garnered increased attention from healthcare providers and caregivers seeking to optimize nutritional intake and maintain health and quality of life in older adults.
There has been a paradigm shift in healthcare paradigms towards preventive and holistic approaches, wherein nutrition plays a central role. Healthcare professionals increasingly recognize the preventive potential of adequate nutrition in mitigating the risk of chronic diseases, boosting immune function, and supporting overall well-being. This recognition has fueled efforts to integrate nutrition assessment and intervention into routine clinical practice, thereby elevating the profile of enteral nutrition as a critical component of comprehensive healthcare delivery.
Restraints:
- High Cost of Enteral Nutrition Products
- Ethical and Legal Considerations
-
Risk of Complications and Adverse Events - One of the primary risks associated with enteral nutrition is the potential for tube-related complications. Enteral feeding tubes, including nasogastric tubes, gastrostomy tubes, and jejunostomy tubes, can cause complications such as tube displacement, tube occlusion, and tube dislodgement. These complications can lead to inadequate delivery of nutrients, aspiration of feed, and gastrointestinal problems, posing risks to patient safety and health outcomes.
Enteral nutrition carries the risk of gastrointestinal intolerance and complications. Some patients may experience symptoms such as nausea, vomiting, diarrhea, bloating, and abdominal cramps when receiving enteral feeds. Gastrointestinal intolerance can result from various factors including feed composition, delivery rate, and underlying gastrointestinal conditions. These complications not only impact patient comfort and compliance but also necessitate adjustments to feeding regimens and may require medical intervention.
Another significant risk associated with enteral nutrition is the potential for infection. Enteral feeding tubes provide a route for microorganisms to enter the gastrointestinal tract, increasing the risk of infection, particularly in immunocompromised patients. Infections such as aspiration pneumonia, catheter-related bloodstream infections, and surgical site infections can occur, leading to serious complications and prolonged hospitalization. Adequate hygiene practices, proper handling of feeding equipment, and regular monitoring are essential to mitigate the risk of infections associated with enteral nutrition.
Enteral nutrition therapy may lead to metabolic complications and nutritional imbalances. Patients receiving enteral feeds may experience electrolyte abnormalities, fluid overload, hyperglycemia, or hypertriglyceridemia, especially if their nutritional requirements are not properly assessed and monitored. Nutritional imbalances can compromise patient health and contribute to the development of complications such as hepatic dysfunction, renal impairment, and metabolic acidosis.
Opportunities:
- Focus on Homecare Settings
- Technological Advancements
-
Focus on Disease-specific Formulations - One of the significant opportunities within the enteral nutrition market lies in the development and commercialization of disease-specific formulations. These formulations are designed to meet the nutritional demands of patients suffering from various medical conditions such as cancer, gastrointestinal disorders, diabetes, renal failure, and others.
There has been a growing recognition of the importance of personalized nutrition in managing and treating chronic diseases. Disease-specific enteral nutrition formulations are formulated with specific macronutrient compositions, micronutrient profiles, and bioactive ingredients targeted towards addressing the nutritional deficiencies and metabolic challenges associated with particular diseases. For instance, in cancer patients undergoing chemotherapy or radiation therapy, maintaining adequate nutritional intake is crucial for supporting immune function, promoting tissue repair, and minimizing treatment-related side effects such as weight loss and muscle wasting. Disease-specific enteral nutrition formulations for cancer patients may include higher protein content, immune-enhancing nutrients, and omega-3 fatty acids to support nutritional status and improve treatment outcomes.
Patients with gastrointestinal disorders such as Crohn's disease or ulcerative colitis often experience malabsorption, nutrient deficiencies, and gastrointestinal inflammation, necessitating specialized enteral nutrition support. Disease-specific formulations tailored for these conditions may contain prebiotics, probiotics, fiber, and specific amino acids to support gut health, reduce inflammation, and improve symptom management.
Competitive Landscape Analysis
Key players in Global Enteral Nutrition Market include:
- Nestlé
- Danone S.A.
- Abbott Laboratories
- FrieslandCampina
- B. Braun SE
- Dr. Schär AG
- Arla Food
- Reckitt Benckiser
- Perrigo Company PLC
- Fonterra Co-operative Group Limited
- Kate Farms
- Nutritional Medicinals
- Fresenius Kabi AG
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Global Enteral Nutrition Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Prevalence of Chronic Diseases
-
Aging Population
-
Increasing Awareness about Clinical Nutrition
-
- Restraints
-
High Cost of Enteral Nutrition Products
-
Ethical and Legal Considerations
-
Risk of Complications and Adverse Events
-
- Opportunities
-
Focus on Homecare Settings
-
Technological Advancements
-
Focus on Disease-specific Formulations
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Enteral Nutrition Market, By Product Type, 2023 - 2033 (USD Million)
-
General
-
Disease Specific
-
- Global Enteral Nutrition Market, By Application, 2023 - 2033 (USD Million)
-
Gastrointestinal Disorders
-
Metabolic/Inborn Errors of Metabolism
-
Food Allergy
-
Renal Disease
-
Liver Disease
-
Oncology
-
Neurology
-
Others
-
- Global Enteral Nutrition Market, By Geography, 2023 - 2033 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Enteral Nutrition Market, By Product Type, 2023 - 2033 (USD Million)
- Competitive Landscape
- Company Profiles
- Nestlé
- Danone S.A.
- Abbott Laboratories
- FrieslandCampina
- B. Braun SE
- Dr. Schär AG
- Arla Food
- Reckitt Benckiser
- Perrigo Company PLC
- Fonterra Co-operative Group Limited
- Kate Farms
- Nutritional Medicinals
- Fresenius Kabi AG
- Company Profiles
- Analyst Views
- Future Outlook of the Market